'Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM' - Author's reply

被引：0
|
作者：
Broman, Niklas [1 ,2 ]
Feuth, Thijs [1 ,2 ]
Oksi, Jarmo [1 ,2 ]
机构：
[1] Turku Univ Hosp, Dept Infect Dis, Turku, Finland
[2] Turku Univ Hosp, Dept Pulm Dis, Turku, Finland
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2022年 / 28卷 / 11期
关键词：
D O I：
10.1016/j.cmi.2022.06.028
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1520 / 1521
页数：2
相关论文
共 50 条
  • [21] LIVER INJURY IN HOSPITALIZED COVID-19 PATIENTS TREATED WITH TOCILIZUMAB
    Kalligeros, Markos
    Shehadeh, Fadi
    Kothadia, Savan
    Marino, Daniel
    Mylona, Evangelia
    Wands, Jack R.
    Mylonakis, Eleftherios
    GASTROENTEROLOGY, 2022, 162 (07) : S1250 - S1251
  • [22] Changes in Inflammatory Markers after Administration of Tocilizumab in COVID-19: A Single-Center Retrospective Study
    Olewicz-Gawlik, Anna
    Ginter-Matuszewska, Barbara
    Kaminski, Mikolaj
    Adamek, Agnieszka
    Bura, Maciej
    Mozer-Lisewska, Iwona
    Kowala-Piaskowska, Arleta
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (01)
  • [23] Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis - Author's reply
    Kashour, Tarek
    Tleyjeh, Imad M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (08) : 1177 - 1178
  • [24] Hydroxychloroquine in Hospitalized Patients with Covid-19 Reply
    Horby, Peter
    White, Nicholas J.
    Landray, Martin J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (09): : 882 - 882
  • [25] Tocilizumab Treatment Leads to Early Resolution of Myeloid Dysfunction and Lymphopenia in Patients Hospitalized With COVID-19
    Bauer, R. N.
    Hackney, J.
    Rosenberger, C.
    Teterina, A.
    Qamra, A.
    Onabajo, O.
    McBride, J.
    Cai, F.
    Bao, M.
    Tsai, L.
    Regev, A.
    Rosas, I. O.
    Shivram, H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [26] In patients hospitalized for COVID-19, tocilizumab reduces mortality at 28 d
    Lo, Carson K. L.
    Chagla, Zain
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (11) : JC125 - JC125
  • [27] Tocilizumab administration in COVID-19 patients: Water on the fire or gasoline?
    Deana, Cristian
    Vetrugno, Luigi
    Bassi, Flavio
    De Monte, Amato
    MEDICAL MYCOLOGY CASE REPORTS, 2021, 31 : 32 - 34
  • [28] Clinical Outcomes of Patients Hospitalized for COVID-19 Infection Treated with Tocilizumab
    Swaney, R.
    Jackson, I.
    Aurit, S.
    Desatche, C.
    Walters, R.
    Vivekanandan, R.
    Narechania, S.
    Velagapudi, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [29] EFFICACY AND SAFETY OF TOCILIZUMAB IN HOSPITALIZED COVID-19 PATIENTS: A SYSTEMATIC REVIEW
    Mahmud, Samia
    Nagraj, Sanjana
    Karia, Rutu
    Karale, Smruti
    Akku, Radhika
    Mehra, Ishita
    Joshi, Avni
    Kashyap, Rahul
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 55 - 55
  • [30] COVID-19 Infections and Inflammatory Markers in Patients Hospitalized During the First Year of the Pandemic
    Kalaiselvan, Parkavi
    Yingchoncharoen, Pitchaporn
    Thongpiya, Jerapas
    Motes, Arunee
    Nugent, Kenneth
    JOURNAL OF PRIMARY CARE AND COMMUNITY HEALTH, 2023, 14
12345